High-grade serous epithelial ovarian cancer, BRCA negative, in two 18-year-old women: case report

被引：0
|
作者：
Cortes-Esteban, Patricia [1 ]
Gomez-Avalos, Julieta [2 ]
Millan-Aguilar, Hugo [3 ]
Adame-Gonzalez, Ignacio [4 ]
Jasso-Sosa, Velma [5 ]
机构：
[1] ISSSTE, Dept Oncol Med, Ctr Med Nacl Noviembre 20, Clin Tumores Ginecol, Mexico City, Mexico
[2] ISSSTE, Dept Oncol Med, Ctr Med Nacl Noviembre 20, Mexico City, Mexico
[3] Fdn Canc Mama, Dept Oncol Med, Mexico City, Mexico
[4] ISSSTE, Dept Med Nucl, Ctr Med Nacl Noviembre 20, Mexico City, Mexico
[5] ISSSTE, Dept Anat Patol, Ctr Med Nacl Noviembre 20, Mexico City, Mexico
来源：
GACETA MEXICANA DE ONCOLOGIA | 2023年 / 22卷
关键词：
Ovarian cancer; BRCA; PARP inhibitor; BEVACIZUMAB;
D O I：
10.24875/j.gamo.220000951
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two previously healthy 18-year-old Mexican women referred for medical evaluation due to ascites. Clinical studies revealed the presence of ovarian-dependent tumors, and elevated CA-125. A diagnostic laparotomy was performed, with a pathology report of a high-grade papillary serous adenocarcinoma. BRCA 1 and 2 was performed and reported negative for both patients. Chemotherapy and antiangiogenic treatment were started. One of the patients was considered a candidate for a poly (ADP-ribose) polymerase inhibitor.
引用
收藏
页码：41 / 46
页数：6
相关论文
共 50 条
  • [21] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [22] First-Line Management of Advanced High-Grade Serous Ovarian Cancer
    Mahmood, Reem D.
    Morgan, Robert D.
    Edmondson, Richard J.
    Clamp, Andrew R.
    Jayson, Gordon C.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (06)
  • [23] Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
    Bouberhan, Sara
    Philp, Lauren
    Hill, Sarah
    Al-Alem, Linah F.
    Rueda, Bo
    CANCERS, 2020, 12 (05)
  • [24] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02) : 136 - 145
  • [25] First-Line Management of Advanced High-Grade Serous Ovarian Cancer
    Reem D. Mahmood
    Robert D. Morgan
    Richard J. Edmondson
    Andrew R. Clamp
    Gordon C. Jayson
    Current Oncology Reports, 2020, 22
  • [26] Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma
    Hyman, David M.
    Long, Kara C.
    Tanner, Edward J.
    Grisham, Rachel N.
    Arnold, Angela G.
    Bhatia, Jasmine
    Phillips, Mary F.
    Spriggs, David R.
    Soslow, Robert A.
    Kauff, Noah D.
    Levine, Douglas A.
    GYNECOLOGIC ONCOLOGY, 2012, 126 (02) : 224 - 228
  • [27] Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women
    Filippova, Olga T.
    Selenica, Pier
    Pareja, Fresia
    Vahdatinia, Mahsa
    Zhu, Yingjie
    Pei, Xin
    Riaz, Nadeem
    Roche, Kara Long
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Ellenson, Lora H.
    Reis-Filho, Jorge S.
    Zamarin, Dmitriy
    Weigelt, Britta
    GYNECOLOGIC ONCOLOGY, 2021, 161 (02) : 545 - 552
  • [28] Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
    Carlota Moya-Alarcón
    Almudena González-Domínguez
    Susana Simon
    Inés Pérez-Román
    Antonio González-Martín
    Eloisa Bayo-Lozano
    Ana Beatriz Sánchez-Heras
    Clinical and Translational Oncology, 2019, 21 : 1076 - 1084
  • [29] Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
    Shen, Yen Ting
    Wang, Lucy
    Evans, James C.
    Allen, Christine
    Piquette-Miller, Micheline
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [30] Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas
    Dowson, Cassandra B.
    Stewart, Colin
    O'Sullivan, Sarah
    Pachter, Nicholas
    Schofield, Lyn
    Cohen, Paul A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (01) : 94 - 99
12345